Lupin Diagnostics Limited (LDL), a wholly owned subsidiary of global pharmaceutical major Lupin Limited, has announced a significant milestone with all 27 of its greenfield laboratories across India now accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL).  The achievement underscores LDL’s commitment to high-quality diagnostics and patient-centric care. NABL accreditation is considered a benchmark for excellence in laboratory operations, ensuring that testing and calibration standards are met with precision and consistency. 

“This accreditation is a testament to the team's dedication to patient care and our mission to promote healthier lives,” said Ravindra Kumar, CEO of Lupin Diagnostics. “The 27 greenfield labs across the country ensure timely and accurate reporting. Our goal is to empower doctors and patients with evidence-based diagnostics.”  Kumar emphasized that Lupin Diagnostics remains focused on continuous innovation and improvement in healthcare delivery, noting that the expansion of accredited labs strengthens the foundation for reliable diagnostic services nationwide.

  LDL’s network of NABL-accredited labs supports a growing demand for quality healthcare services, particularly in underserved regions. The company has been steadily expanding its footprint, ensuring that patients and physicians alike have access to accurate and timely diagnostic insights essential for effective treatment decisions. 

With this development, Lupin Diagnostics further solidifies its position as a trusted provider in the rapidly evolving diagnostic landscape .